New York, NY, United States of America

Katherine Woods

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: California Institute of Technology. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katherine Woods. Retrieved from https://idiyas.com/inventor/katherine-woods-3mh3qltb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katherine Woods: Innovator in T Cell Receptor Research

Introduction

Katherine Woods is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of immunology, particularly in the development of T cell receptors. Her work is crucial for advancing cancer therapies and understanding immune responses.

Latest Patents

Katherine Woods holds a patent titled "Composition of NY-ESO-1-Specific T Cell Receptors Restricted on Multiple Major Histocompatibility Complex Molecules." This patent represents her innovative approach to enhancing T cell receptor specificity, which is vital for targeted cancer treatments. She has 1 patent to her name.

Career Highlights

Katherine is affiliated with the California Institute of Technology, where she conducts her research. Her work has garnered attention for its potential applications in therapeutic settings, particularly in oncology. She is recognized for her dedication to advancing scientific knowledge and improving patient outcomes.

Collaborations

Katherine Woods has collaborated with notable colleagues, including Owen N. Witte and Jami McLaughlin Witte. These partnerships have enriched her research and contributed to the success of her projects.

Conclusion

Katherine Woods is a trailblazer in the field of T cell receptor research, with a focus on innovative solutions for cancer treatment. Her contributions are paving the way for future advancements in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…